http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011153123-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a80f651c538b39df6451492acdda5ab |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 |
| filingDate | 2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab40feab52d8ee3933a197a350c6083c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abb095014545f86aa2b759bf85ae1656 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cbfa9dd81fdac273d7bd6c1a9689c63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c0ba63b86912aa77029f75b93650030 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64542f0d04eda596c9a7b18de9ac7a45 |
| publicationDate | 2011-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011153123-A |
| titleOfInvention | Transdermal absorption preparation containing tulobuterol |
| abstract | An object of the present invention is to provide a transdermal absorption preparation containing tulobuterol which is safe to the skin, has a high transdermal absorption rate, and has excellent medicinal durability and adhesive strength. Another object of the present invention is to provide a percutaneous absorption preparation containing tulobuterol that is safely absorbed into the skin in the state in which tulobuterol is dissolved, without including a transdermal absorbent. A drug layer containing tulobuterol and a natural rubber-based adhesive base, and a support attached to one surface of the drug layer and supporting the drug layer, wherein the natural rubber-based adhesive base is 10 parts by weight to It comprises 40 parts by weight of natural rubber, 54.5 parts by weight to 85 parts by weight of a rosin ester resin and an acid value regulator, and constitutes a transdermally absorbable preparation having a drug layer thickness of 25 μm to 75 μm. [Selection] Figure 1 |
| priorityDate | 2010-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.